Photo by nci from unsplash
We compared an FDA cleared molecular meningitis/encephalitis panel to lab developed viral PCRs and bacterial culture. Of the 67 viral PCR or bacterial culture-positive samples, 92.5% were positive for the… Click to show full abstract
We compared an FDA cleared molecular meningitis/encephalitis panel to lab developed viral PCRs and bacterial culture. Of the 67 viral PCR or bacterial culture-positive samples, 92.5% were positive for the same target by the panel. Of the 66 negative samples tested, no targets were detected by the panel, for an agreement of 96.2%.
Keywords:
panel;
comparative evaluation;
evaluation filmarray;
meningitis encephalitis
Journal Title: Diagnostic microbiology and infectious disease
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diagnostic microbiology and infectious disease
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!